SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007267
Filing Date
2019-03-12
Accepted
2019-03-12 09:28:56
Documents
8
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K krys-10k_20181231.htm 10-K 2247233
2 EX-23.1 krys-ex231_7.htm EX-23.1 2956
3 EX-31.1 krys-ex311_8.htm EX-31.1 19831
4 EX-31.2 krys-ex312_10.htm EX-31.2 19793
5 EX-32.1 krys-ex321_11.htm EX-32.1 9958
6 EX-32.2 krys-ex322_6.htm EX-32.2 9710
7 GRAPHIC ghvyui2c1mds000001.jpg GRAPHIC 21449
8 GRAPHIC ghvyui2c1mds000002.jpg GRAPHIC 23751
  Complete submission text file 0001564590-19-007267.txt   2373063
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38210 | Film No.: 19674130
SIC: 2836 Biological Products, (No Diagnostic Substances)